Genotyping Neisseria gonorrhoeae gyrA and penA antimicrobial genes from remnant Neisseria gonorrhoeae positive Cepheid Xpert® clinical specimens - A feasibility study
- PMID: 31760050
- PMCID: PMC11964821
- DOI: 10.1016/j.mimet.2019.105783
Genotyping Neisseria gonorrhoeae gyrA and penA antimicrobial genes from remnant Neisseria gonorrhoeae positive Cepheid Xpert® clinical specimens - A feasibility study
Abstract
Neisseria gonorrhoeae (NG) has developed resistance to most antibiotics, making it increasingly difficult to treat. Previous studies have predicted antimicrobial NG susceptibility based on the antimicrobial gene target DNA gyrase subunit A (gyrA) codon serine 91 and the penicillin-binding protein 2 (penA) using Roche Cobas® and Hologic APTIMA™ clinical specimens. We studied whether similar methods could be used on remnant NG-positive Cepheid Xpert® specimens.
Keywords: Antibiotic resistance; Genotyping; Neisseria gonorrhoeae; gyrA; penA.
Copyright © 2019 Elsevier B.V. All rights reserved.
References
-
- Bissessor M, Tabrizi SN, Fairley CK, Danielewski J, Whitton B, Bird S, … Chen MY (2011). Differing Neisseria gonorrhoeae Bacterial Loads in the Pharynx and Rectum in Men Who Have Sex with Men: Implications for Gonococcal Detection, Transmission, and Control. Journal of Clinical Microbiology, 49(12), 4304–4306. 10.1128/JCM.05341-11 - DOI - PMC - PubMed
-
- Bristow CC, McGrath MR, Cohen AC, Anderson LJ, Gordon KK, & Klausner JD (2017). Comparative evaluation of 2 nucleic acid amplification tests for the detection of chlamydia trachomatis and neisseria gonorrhoeae at extragenital sites. Sexually Transmitted Diseases. 10.1097/OLQ.0000000000000627 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
